Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes

Studi randomized ini membandingkan antara efek diet low-carbohydrate Mediterranean-style (LC) dengan diet low-fat  (LF) untuk orang2 yang baru terdiagnosis DM tipe 2. Setelah 4 tahun pasien yang menjalankan diet  LC 44% perlu obat antihiperglikemia, sedangkan pasien yang menjalankan diet LF 70% perlu obat antihiperglikemia (absolute difference, –26.0 percentage points [95% CI, –31.1 to –20.1 percentage points]; hazard ratio, 0.63 [CI, 0.51 to 0.86]; hazard ratio adjusted for weight change, 0.70 [CI, 0.59 to 0.90]; P < 0.001).  Pasien yang menjalankan diet LC juga mengalami penurunan BB lebih besar dan mengalami perbaikan kontrol glikemik sera risiko koroner yang lebih rendah dibandingkan yang menjalankan diet LF. 

Satu lagi bukti bahwa diet rendah karbohidrat (Mediterrania style) lebih unggul dibandingkan diet rendah lemak.

Annals of Internal Medicine 151(5):306-314, 1 September 2009 © 2009 to the American College of Physicians
Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes-A Randomized Trial. Katherine Esposito, Maria Ida Maiorino, Miryam Ciotola, et al.

Background: Low-carbohydrate and low-fat calorie-restricted diets are recommended for weight loss in overweight and obese people with type 2 diabetes.

Objective: To compare the effects of a low-carbohydrate Mediterranean-style or a low-fat diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes.

Design: Single-center, randomized trial. Randomization was computer-generated and unstratified. Allocation was concealed in sealed study folders held in a central, secure location until participants gave informed consent. Participants and investigators were aware of treatment assignment, and assessors of the primary outcome were blinded.

Setting: Teaching hospital in Naples, Italy.

Patients: 215 overweight people with newly diagnosed type 2 diabetes who were never treated with antihyperglycemic drugs and had hemoglobin A_1c (HbA_1c) levels less than 11%.

Intervention: Mediterranean-style diet (<50% of daily calories from carbohydrates) (n = 108) or a low-fat diet (<30% of daily calories from fat) (n = 107).

Measurements: Start of antihyperglycemic drug therapy, defined by protocol as indicated for follow-up HbA_1c level greater than 7% (primary outcome), and changes in weight, glycemic control, and coronary risk factors (secondary outcomes).

Results: After 4 years, 44% of patients in the Mediterranean-style diet group and 70% in the low-fat diet group required treatment (absolute difference, –26.0 percentage points [95% CI, –31.1 to –20.1 percentage points]; hazard ratio, 0.63 [CI, 0.51 to 0.86]; hazard ratio adjusted for weight change, 0.70 [CI, 0.59 to 0.90]; P < 0.001). Participants assigned to the Mediterranean-style diet lost more weight and experienced greater improvements in some glycemic control and coronary risk measures than did those assigned to the low-fat diet.

Limitations: Investigators responsible for initiating drug therapy were not blinded to treatment assignment. Dietary intake was self-reported.

Conclusion: Compared with a low-fat diet, a low-carbohydrate, Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for antihyperglycemic drug therapy in overweight patients with newly diagnosed type 2 diabetes.